FI20002505L - 5-aryyli-indolijohdannaisia - Google Patents

5-aryyli-indolijohdannaisia Download PDF

Info

Publication number: FI20002505L
Authority: FI; Finland
Prior art keywords: indole derivatives; aryl indole; aryl; derivatives; indole
Prior art date: 1992-11-02

Application number

FI20002505A

Other languages

English (en)

Swedish (sv)

Other versions

FI20002505A7 (fi

Inventor

John Eugene Macor

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-11-02

Filing date

2000-11-15

Publication date

2000-11-15

2000-11-15 Application filed by Pfizer filed Critical Pfizer

2000-11-15 Publication of FI20002505A7 publication Critical patent/FI20002505A7/fi

2000-11-15 Publication of FI20002505L publication Critical patent/FI20002505L/fi

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Child & Adolescent Psychology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Saccharide Compounds (AREA)

FI20002505A 1992-11-02 2000-11-15 5-aryyli-indolijohdannaisia FI20002505L (fi)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US97075892A	1992-11-02	1992-11-02

Publications (2)

Publication Number	Publication Date
FI20002505A7 FI20002505A7 (fi)	2000-11-15
FI20002505L true FI20002505L (fi)	2000-11-15

Family

ID=25517470

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
FI934825A FI111257B (fi)	1992-11-02	1993-11-01	Menetelmä terapeuttisesti käyttökelpoisten 5-aryyli-indolijohdannaisten valmistamiseksi sekä uudet välituoteyhdisteet
FI20002505A FI20002505L (fi)	1992-11-02	2000-11-15	5-aryyli-indolijohdannaisia

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
FI934825A FI111257B (fi)	1992-11-02	1993-11-01	Menetelmä terapeuttisesti käyttökelpoisten 5-aryyli-indolijohdannaisten valmistamiseksi sekä uudet välituoteyhdisteet

Country Status (27)

Country	Link
US (1)	US5886008A (fi)
EP (2)	EP0666858B1 (fi)
JP (1)	JP2788551B2 (fi)
KR (1)	KR0163371B1 (fi)
CN (1)	CN1051313C (fi)
AT (1)	ATE202102T1 (fi)
AU (1)	AU685066B2 (fi)
BR (1)	BR9307348A (fi)
CA (2)	CA2148380C (fi)
CZ (1)	CZ283001B6 (fi)
DE (1)	DE69330351T2 (fi)
DK (1)	DK0666858T3 (fi)
EG (1)	EG20396A (fi)
ES (1)	ES2157224T3 (fi)
FI (2)	FI111257B (fi)
GR (1)	GR3036579T3 (fi)
HU (1)	HU222235B1 (fi)
IL (1)	IL107386A (fi)
MY (1)	MY109696A (fi)
NO (1)	NO309652B1 (fi)
NZ (1)	NZ257059A (fi)
PL (1)	PL176091B1 (fi)
PT (1)	PT666858E (fi)
RU (1)	RU2134266C1 (fi)
TW (1)	TW251284B (fi)
WO (1)	WO1994010171A1 (fi)
ZA (1)	ZA938137B (fi)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9210400D0 (en) *	1992-05-15	1992-07-01	Merck Sharp & Dohme	Therapeutic agents
CA2169179C (en) *	1993-08-31	2000-02-29	John E. Macor	5-arylindole derivatives
KR970701182A (ko) *	1994-02-10	1997-03-17	스피겔 알렌 제이	벤조다이아제핀 수용체 부위의 작용물질 및 길항물질로서의 5-헤테로아릴인돌 유도체(5-heteroarylindole derivatives as benzodiazepine receptor site agonists and antagonists)
GB9420529D0 (en)	1994-10-12	1994-11-30	Pfizer Ltd	Indoles
AU702322B2 (en) *	1995-03-20	1999-02-18	Eli Lilly And Company	5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1h-indoles: new 5-ht1f agonists
AU7261196A (en) *	1995-10-10	1997-04-30	Eli Lilly And Company	N-{2-substituted-3-(2-aminoethyl)-1h-indol-5-yl}-amides: new 5-ht1f agonists
JP2002507996A (ja)	1997-07-03	2002-03-12	デュポンファーマシューティカルズカンパニー	神経学的障害を治療するためのイミダゾピリミジン類およびイミダゾピリジン類
US6465484B1 (en)	1997-09-26	2002-10-15	Merck & Co., Inc.	Angiogenesis inhibitors
US7189753B1 (en)	1997-11-06	2007-03-13	Cady Roger K	Preemptive prophylaxis of migraine
JP2002519321A (ja) *	1998-06-30	2002-07-02	イーライ・リリー・アンド・カンパニー	セロトニン関連系に効果を有するピロリジン、及び、ピロリン誘導体
US6365589B1 (en)	1998-07-02	2002-04-02	Bristol-Myers Squibb Pharma Company	Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
GB9819035D0 (en) *	1998-09-01	1998-10-28	Cerebrus Res Ltd	Chemical compounds VII
US5994352A (en) *	1998-11-13	1999-11-30	Pfizer Inc.	5-arylindole derivatives
PE20030008A1 (es)	2001-06-19	2003-01-22	Bristol Myers Squibb Co	Inhibidores duales de pde 7 y pde 4
US7399764B2 (en)	2002-10-30	2008-07-15	Merck & Co., Inc.	Inhibitors of Akt activity
US20040102360A1 (en) *	2002-10-30	2004-05-27	Barnett Stanley F.	Combination therapy
US7332508B2 (en) *	2002-12-18	2008-02-19	Novo Nordisk A/S	Substituted homopiperidine, piperidine or pyrrolidine derivatives
CN1809351A (zh)	2003-04-24	2006-07-26	麦克公司	Akt活性抑制剂
DE10337184A1 (de)	2003-08-13	2005-03-10	Gruenenthal Gmbh	Substituierte 3-Pyrrolidin-Indol-Derivate
KR20060119871A (ko) *	2003-08-21	2006-11-24	오에스아이 파마슈티컬스, 인코포레이티드	Ｎ３―치환된 이미다조피리딘 ｃ―ｋｉｔ 억제제
US7442709B2 (en) *	2003-08-21	2008-10-28	Osi Pharmaceuticals, Inc.	N3-substituted imidazopyridine c-Kit inhibitors
EP1673087B1 (en)	2003-10-03	2015-05-13	3M Innovative Properties Company	Alkoxy substituted imidazoquinolines
AU2004293078B2 (en)	2003-11-25	2012-01-19	3M Innovative Properties Company	Substituted imidazo ring systems and methods
DE102004014304A1 (de) *	2004-03-22	2005-10-06	Grünenthal GmbH	Substituierte 1,4,8- Triazaspiro[4,5]decan-2-on-Verbindungen
JP2008530022A (ja)	2005-02-04	2008-08-07	コーリーファーマシューティカルグループ，インコーポレイテッド	免疫反応調節物質を含む水性ゲル処方物
ES2346157T3 (es) *	2006-03-22	2010-10-11	Janssen Pharmaceutica N.V.	Derivados de alquilaminas ciclicas como inhibidores de la interaccion entre mdm2 y p53.
WO2014078568A1 (en)	2012-11-14	2014-05-22	The Johns Hopkins University	Methods and compositions for treating schizophrenia
EP2968220B1 (en)	2013-03-15	2021-05-05	Agenebio, Inc.	Methods and compositions for improving cognitive function
WO2014144663A1 (en)	2013-03-15	2014-09-18	The Johns Hopkins University	Methods and compositions for improving cognitive function
AU2016255431B2 (en)	2015-04-29	2020-05-07	Janssen Pharmaceutica Nv	Imidazopyrazines and pyrazolopyrimidines and their use as AMPA receptor modulators
HRP20210403T1 (hr)	2015-04-29	2021-10-29	Janssen Pharmaceutica Nv	Azabenzimidazoli i njihova uporaba kao modulatora ampa receptora
WO2016176449A1 (en)	2015-04-29	2016-11-03	Janssen Pharmaceutica Nv	Benzimidazolone and benzothiazolone compounds and their use as ampa receptor modulators
ES2767707T3 (es)	2015-04-29	2020-06-18	Janssen Pharmaceutica Nv	Compuestos de indolona y su uso como moduladores de receptor AMPA
NZ738682A (en)	2015-05-22	2022-01-28	Agenebio Inc	Extended release pharmaceutical compositions of levetiracetam
CN108137561B (zh)	2015-11-06	2021-03-26	豪夫迈·罗氏有限公司	二氢吲哚-2-酮衍生物
WO2017076931A1 (en)	2015-11-06	2017-05-11	F. Hoffmann-La Roche Ag	Indolin-2-one derivatives for use in the treatment of cns and related disorders
EP3371170B1 (en)	2015-11-06	2019-07-31	H. Hoffnabb-La Roche Ag	Indolin-2-one derivatives useful in the treatment of cns diseases
RU2727179C2 (ru)	2015-11-06	2020-07-21	Ф. Хоффманн-Ля Рош Аг	Производные индолин-2-она
CN111822047B (zh) *	2020-07-17	2022-05-27	曲阜师范大学	一种磁性介孔聚合离子液体负载催化合成吲哚类衍生物的方法
WO2025104490A1 (en) *	2023-11-14	2025-05-22	Mindset Pharma Inc.	Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto
WO2025104491A1 (en)	2023-11-14	2025-05-22	Mindset Pharma Inc.	Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA795239B (en) *	1978-10-12	1980-11-26	Glaxo Group Ltd	Heterocyclic compounds
BE889931A (fr) *	1980-08-12	1982-02-11	Glaxo Group Ltd	Derives indoliques, leur preparation et leurs applications en tant que medicaments
US4983622A (en) *	1984-02-06	1991-01-08	Eli Lilly And Company	6-substituted-4-dialkylaminotetrahydrobenz(c,d)indoles
GB8600397D0 (en) *	1986-01-08	1986-02-12	Glaxo Group Ltd	Chemical compounds
GB8719167D0 (en) *	1987-08-13	1987-09-23	Glaxo Group Ltd	Chemical compounds
GB8724912D0 (en) *	1987-10-23	1987-11-25	Wellcome Found	Indole derivatives
GB8819024D0 (en) *	1988-08-10	1988-09-14	Glaxo Group Ltd	Chemical compounds
IL96891A0 (en) *	1990-01-17	1992-03-29	Merck Sharp & Dohme	Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them
US5340838A (en) *	1990-05-04	1994-08-23	Eli Lilly And Company	Method of inhibiting gastric acid secretion with 2-phenylcyclopropylamines
CA2042295A1 (fr) *	1990-05-15	1991-11-16	Jacques Chauveau	Derives de mediateurs endogenes, leurs sels, procede de preparation, applications, et compositions les renfermant
KR100215627B1 (ko) *	1990-06-07	1999-08-16	레슬리 제인 에드워즈	치료용 헤테로사이클 화합물
DK158590D0 (da) *	1990-07-02	1990-07-02	Lundbeck & Co As H	Indolderivater
CA2091562C (en) *	1990-10-15	2001-03-27	John Eugene Macor	Indole derivatives useful in psychotherapeutics
SK278998B6 (sk) *	1991-02-01	1998-05-06	Merck Sharp & Dohme Limited	Deriváty imidazolu, triazolu a tetrazolu, spôsob i
FR2672602B1 (fr) *	1991-02-12	1993-06-04	Centre Nat Rech Scient	Composes derives des beta-carbolines ligands du recepteur des benzodiazepines ayant un effet agoniste inverse et antagoniste vis-a-vis des benzodiazepines et medicaments les contenant.
US5229401A (en) *	1991-09-23	1993-07-20	Hoechst-Roussel Pharmaceuticals Incorporated	Substituted pyridinylamino benzo[b]thiophene compounds
US5187159A (en) *	1991-10-07	1993-02-16	Merck & Co., Inc.	Angiotensin II antagonists incorporating a substituted 1,3-benzodioxole or 1,3-benzodithiole
GB9210400D0 (en) *	1992-05-15	1992-07-01	Merck Sharp & Dohme	Therapeutic agents
US5378846A (en) *	1993-06-11	1995-01-03	Russian-American Institute For New Drug Development	1,2,3,4-tetrahydropyrrolo-[1,2-a]-pyrazine derivatives

1993
- 1993-10-16 TW TW082108604A patent/TW251284B/zh active
- 1993-10-19 WO PCT/US1993/009790 patent/WO1994010171A1/en not_active Ceased
- 1993-10-19 CA CA002148380A patent/CA2148380C/en not_active Expired - Fee Related
- 1993-10-19 CZ CZ951108A patent/CZ283001B6/cs not_active IP Right Cessation
- 1993-10-19 EP EP93923389A patent/EP0666858B1/en not_active Expired - Lifetime
- 1993-10-19 DK DK93923389T patent/DK0666858T3/da active
- 1993-10-19 KR KR1019950701729A patent/KR0163371B1/ko not_active Expired - Fee Related
- 1993-10-19 JP JP6511101A patent/JP2788551B2/ja not_active Expired - Lifetime
- 1993-10-19 ES ES93923389T patent/ES2157224T3/es not_active Expired - Lifetime
- 1993-10-19 EP EP00124422A patent/EP1094064A1/en not_active Withdrawn
- 1993-10-19 CA CA002340999A patent/CA2340999C/en not_active Expired - Fee Related
- 1993-10-19 DE DE69330351T patent/DE69330351T2/de not_active Expired - Fee Related
- 1993-10-19 US US08/424,357 patent/US5886008A/en not_active Expired - Fee Related
- 1993-10-19 PT PT93923389T patent/PT666858E/pt unknown
- 1993-10-19 BR BR9307348A patent/BR9307348A/pt not_active Application Discontinuation
- 1993-10-19 NZ NZ257059A patent/NZ257059A/en unknown
- 1993-10-19 AU AU53294/94A patent/AU685066B2/en not_active Ceased
- 1993-10-19 RU RU95109927/04A patent/RU2134266C1/ru not_active IP Right Cessation
- 1993-10-19 AT AT93923389T patent/ATE202102T1/de not_active IP Right Cessation
- 1993-10-25 IL IL10738693A patent/IL107386A/en not_active IP Right Cessation
- 1993-11-01 MY MYPI93002280A patent/MY109696A/en unknown
- 1993-11-01 FI FI934825A patent/FI111257B/fi not_active IP Right Cessation
- 1993-11-01 CN CN93120716A patent/CN1051313C/zh not_active Expired - Fee Related
- 1993-11-01 ZA ZA938137A patent/ZA938137B/xx unknown
- 1993-11-02 HU HU9303118A patent/HU222235B1/hu not_active IP Right Cessation
- 1993-11-02 EG EG69793A patent/EG20396A/xx active
1995
- 1995-04-28 NO NO951633A patent/NO309652B1/no not_active IP Right Cessation
- 1995-05-01 PL PL93308669A patent/PL176091B1/pl unknown
2000
- 2000-11-15 FI FI20002505A patent/FI20002505L/fi unknown
2001
- 2001-09-11 GR GR20010401436T patent/GR3036579T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
CA2340999C (en)	2005-01-04
RU2134266C1 (ru)	1999-08-10
EP0666858B1 (en)	2001-06-13
CN1094727A (zh)	1994-11-09
FI111257B (fi)	2003-06-30
PL308669A1 (en)	1995-08-21
FI934825L (fi)	1994-05-03
PL176091B1 (pl)	1999-04-30
ES2157224T3 (es)	2001-08-16
JPH07508759A (ja)	1995-09-28
CZ110895A3 (en)	1995-11-15
FI20002505A7 (fi)	2000-11-15
CN1051313C (zh)	2000-04-12
NO309652B1 (no)	2001-03-05
KR950704313A (ko)	1995-11-17
RU95109927A (ru)	1997-01-10
DK0666858T3 (da)	2001-08-27
AU5329494A (en)	1994-05-24
NO951633D0 (no)	1995-04-28
CA2340999A1 (en)	1994-05-11
NZ257059A (en)	1997-07-27
US5886008A (en)	1999-03-23
HU222235B1 (hu)	2003-05-28
JP2788551B2 (ja)	1998-08-20
CA2148380A1 (en)	1994-05-11
ZA938137B (en)	1995-05-02
AU685066B2 (en)	1998-01-15
CZ283001B6 (cs)	1997-12-17
BR9307348A (pt)	1999-05-11
DE69330351T2 (de)	2001-09-20
EP1094064A1 (en)	2001-04-25
PT666858E (pt)	2001-09-28
FI934825A0 (fi)	1993-11-01
MY109696A (en)	1997-04-30
TW251284B (fi)	1995-07-11
EP0666858A1 (en)	1995-08-16
GR3036579T3 (en)	2001-12-31
WO1994010171A1 (en)	1994-05-11
CA2148380C (en)	2001-08-14
EG20396A (en)	1999-02-28
KR0163371B1 (ko)	1998-12-01
DE69330351D1 (de)	2001-07-19
NO951633L (no)	1995-04-28
ATE202102T1 (de)	2001-06-15
HUT66011A (en)	1994-08-29
IL107386A (en)	1999-03-12
IL107386A0 (en)	1994-01-25

Publication	Publication Date	Title
FI20002505A7 (fi)	2000-11-15	5-aryyli-indolijohdannaisia
NO943913L (no)	1994-12-14	Indol-derivater
FI944969A7 (fi)	1995-04-23	Indolijohdannaisia
FI942395A7 (fi)	1994-05-24	Indolijohdannaiset
FI933551A7 (fi)	1993-08-11	5-heteroyyli-indolijohdannaisia
FI930208L (fi)	1993-07-21	Kinazolinderivat
FI935431A7 (fi)	1994-06-11	Kiantsoliinijohdannaisia
FI980341L (fi)	1998-02-13	2-oksi-indolijohdannaisia
FI933037A7 (fi)	1994-01-03	Tiazolylvinylfenylderivat
NL300035I1 (nl)	2001-03-01	Gesubstitueerde thiahzolidinedionderivaten.
FI941423A7 (fi)	1994-05-27	17beta-substituoidut 4-atsa-5alfa-androstan-3-onijohdannaiset
FI931558A7 (fi)	1993-10-08	Indolin johdannaisia
NO961475L (no)	1996-04-12	Indol-derivater
FI945042A7 (fi)	1994-10-26	1-piperatsino-1,2-dihydroindeenijohdannaiset
NO932146D0 (no)	1993-06-11	Benzimidazolderivater
DE69330497D1 (de)	2001-08-30	Chinazolin-derivate
FI20010214A7 (fi)	2001-02-05	Asyyliaminoindolijohdannaisia
DE69212058D1 (de)	1996-08-14	Indol-Derivate
DE59308714D1 (de)	1998-07-30	Cyclobutan-benzol-derivate
FI20002460L (fi)	2000-11-09	4-difenyylimetyylipiperidiinijohdannaisia
NO930520D0 (no)	1993-02-12	Bifenyl-substituerte kinolinderivater
FI925774A7 (fi)	1993-06-21	Indolijohdannaiset
NO952288D0 (no)	1995-06-09	Benzazepinon-derivater
DE69313890D1 (de)	1997-10-23	5-Aminoflavon-Derivate
FI930367L (fi)	1993-08-01	Puridinderivat